Rose V. Thomas
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Virology 12
- HIV Research and Treatment 12
-
- HIV/AIDS drug development and treatment 16
- HIV/AIDS Research and Interventions 5
- Co-authors
- Robert YarchoanSamuel BroderCharles E. MyersJames M. PludaDavid G. JohnsNanette McAteeHiroaki MitsuyaRaymond W. Klecker
- Journals
- Clinical Pharmacology & Therapeutics (4 papers)The Lancet (2 papers)Clinical Infectious Diseases (1 paper)Investigational New Drugs (1 paper)Cancer Nursing (1 paper)
- Partner nations
- United StatesUkraineMalaysia
In The Last Decade
Rose V. Thomas
20 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 107
- Virology 1.1k
- Infectious Diseases 1.3k
- Epidemiology 567
- Emergency Medicine 128
- Hepatology 83
Countries citing papers authored by Rose V. Thomas
This map shows the geographic impact of Rose V. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rose V. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rose V. Thomas more than expected).
Fields of papers citing papers by Rose V. Thomas
This network shows the impact of papers produced by Rose V. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rose V. Thomas. The network helps show where Rose V. Thomas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rose V. Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A survey of links between mental health professionals and general practice in six district health authorities. | 1992 | 28 |
| 2 | 1991 | 45 | |
| 3 | Phase I and pharmacokinetic study of arabinofuranosyl-5-azacytosine (fazarabine, NSC 281272). | 1990 | 15 |
| 4 | 1990 | 54 | |
| 5 | 1990 | 168 | |
| 6 | 1990 | 35 | |
| 7 | 1990 | 9 | |
| 8 | 1990 | 16 | |
| 9 | 1990 | 32 | |
| 10 | 1990 | 50 | |
| 11 | 1990 | 115 | |
| 12 | 1990 | 1 | |
| 13 | 1989 | 320 | |
| 14 | 1989 | 95 | |
| 15 | 1989 | 369 | |
| 16 | 1988 | 72 | |
| 17 | 1988 | 90 | |
| 18 | 1988 | 57 | |
| 19 | 1987 | 261 | |
| 20 | 1987 | 333 |
About Rose V. Thomas
Rose V. Thomas is a scholar working on Virology, Infectious Diseases, Epidemiology, Genetics and Microbiology, having authored 20 papers that have together received 2.2k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (16 papers), HIV Research and Treatment (12 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers), HIV/AIDS Research and Interventions (5 papers), Chronic Lymphocytic Leukemia Research (2 papers), Biochemical and Molecular Research (2 papers), Acute Myeloid Leukemia Research (1 paper) and Nursing Roles and Practices (1 paper). The work is most often cited by research in Virology (1.1k citations), Infectious Diseases (1.3k citations), Epidemiology (567 citations), Emergency Medicine (128 citations) and Hepatology (83 citations). Rose V. Thomas has collaborated with scholars based in United States, Ukraine and Malaysia. Frequent co-authors include Robert Yarchoan, Samuel Broder, Charles E. Myers, James M. Pluda, David G. Johns, Nanette McAtee, Hiroaki Mitsuya, Raymond W. Klecker, C.A. Stein and R. V. Larocca. Their work appears in journals such as Clinical Pharmacology & Therapeutics, The Lancet, Clinical Infectious Diseases, Investigational New Drugs and Cancer Nursing.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.